FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Friday

 

Merck Joins with HAPPYneuron to Add Cognitive Training Games to MSdialog










































Merck Biopharma  announced it has entered into a partnership with a French subsidiary called HAPPYneuron, and now has an exclusive license to that company’s cognitive remediation training program for MS. The program, a series of brain training games and exercises, will be made available to people needing it through Merck’s MSdialog platform.

An e-Health platform, MSdialog is a multi-tenant and cloud-based software system developed to help MS patients — and their healthcare providers — to better manage the disease. It tracks medication schedules (Rebif, or interferon beta-1a), syncs with the RebiSmart auto-injector, monitors treatment adherence and clinical data, and helps patients to chart their health status through questionnaires.

“We have a long-standing commitment to delivering therapeutic and support solutions to people living with MS,” Rehan Verjee, Merck’s chief marketing and strategy officer, said in a press release. “The platform will enhance the attractiveness of MSdialog to patients and HCPs [healthcare professionals] by seeking to address these cognitive deficit symptoms and further fostering the monitoring of the cognitive state of patients.”

HAPPYneuron, a subsidiary of SBT Group of France, created the training games to address the challenges confronting people with MS. The games, refined through 10 years of clinical data, cover a range of cognitive areas and automatically adjust skill levels to match an individual, helping to ensure ease of use.

“We are very proud that Merck chose our program,” said  Franck Tarpin-Bernard, president of HAPPYneuron. “This agreement is a strong acknowledgement of the hard work we have achieved these past years to build training programs adapted to the uniqueness of each medical condition. It reinforces our willingness to become a world leader of digital cognitive remediation.”

MSdialog is currently available in 24 countries. According to the release, the HAPPYneuron training program will initially be made available to patients using MSdialog in Brazil, Argentina, Israel, Italy, France, and the Netherlands.

Story Source: The above story is based on materials provided by MULTIPLESCLEROSISNEWSTODAY
Note: Materials may be edited for content and length


Go to Newer News Go to Older News